Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
09/2001
09/05/2001EP1129094A2 Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same
09/05/2001EP1129093A1 Pyrazolopyrimidinone derivatives for the treatment of impotence
09/05/2001EP1129092A1 Porphyrin compounds, their conjugates and assay methods based on the use of said conjugates
09/05/2001EP1129091A2 Crf receptor antagonists and methods relating thereto
09/05/2001EP1129089A1 Spiro-indolines as y5 receptor antagonists
09/05/2001EP0799038B1 NEW USES OF INDOLO-[2,3b]-QUINOXALINES
09/05/2001CN1311787A Oxazolidinone derivatives, process for their prepn. and pharmaceutical compositions contg. same
09/05/2001CN1311680A Pyrrolo [2,3d] pyrimidine compositions and their use
09/05/2001CN1311186A Deuteroporphyvin derivative, its preparing method and freeze dried preparation for injection
09/05/2001CN1070368C Method for prepn. of pharmaceutical composition contg. imidazo [2,1-6] [3] benzoazepine derivatives
09/04/2001US6284896 Abeo-ergoline derivatives as 5HT1A ligands
09/04/2001US6284890 Aqueous process for the preparation of linear quinacridones having a reduced particle size
09/04/2001US6284772 Indolo[2,1-B] quinazole-6,12-dione antimalarial compounds and methods of treating malaria therewith
09/04/2001US6284766 9H-pyrimido [4,5-b] indole derivatives: CRF1 specific ligands
09/04/2001US6284764 Antiproliferative agent
09/04/2001US6284762 Fungicidal 6-(2-halo-4-alkoxyphenyl)-triazolopyrimidines
09/04/2001US6284757 Antiserotinone agent
08/2001
08/30/2001WO2001062760A2 A NOVEL CRYSTALLINE FORM OF N-[4-[2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO[2,3-d]PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMIC ACID AND PROCESS THEREFOR
08/30/2001WO2001062759A1 Cationic pyrrolo-pyrrol-derivatives, method for producing them and colorants for keratin fibres, containing these compounds
08/30/2001WO2001062758A1 Pteridine compounds for the treatment of psoriasis
08/30/2001WO2001062744A2 Substituted piperazine compounds
08/30/2001US20010018515 Photonic or electronic energy conducting
08/30/2001DE19959958A1 Thiazolylharnstoff-Derivate Thiazolylharnstoff derivatives
08/30/2001DE10009000A1 Verfahren zur Herstellung substituierter Indole A process for the preparation of substituted indoles
08/30/2001CA2657986A1 Substituted piperazine compounds
08/29/2001EP1127874A2 Process for the preparation of substituted indoles
08/29/2001EP1127871A1 New esters derived from substituted phenyl-cyclohexyl compounds
08/29/2001EP1127265A1 Method for non-invasive imaging oxygen distribution in multi-dimensions and apparatus therefor
08/29/2001EP1126855A1 Methods for preventing/treating damage to sensory hair cells and cochlear neurons
08/29/2001EP0828741B1 Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones
08/29/2001CN1310721A Medicine nitrate salts
08/29/2001CN1310705A Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation
08/28/2001US6281363 Antiinflammatory agents; antiarthritic agents; autoimmune disorders
08/28/2001US6281354 Analogs of duocarmycin and cc-1065
08/28/2001US6281353 Method of making diazepine derivatives
08/28/2001US6281233 Method of treating gastrointestinal motility disorders
08/28/2001US6281232 Azabicyclic ring-substituted thia- or oxadiazoles
08/28/2001US6281226 Pleuromutilin derivatives as antimicrobials
08/28/2001US6281220 Pyrrolo(3,2-d)pyrimidin-4-amines and pyrrolo(3,2-b)pyridin-4-amines, and their use as antagonists of corticotropin-releasing factor
08/28/2001US6280959 Zinc chelated cell surface receptor ligands for use as agonist of dimeric cell surface receptors; for example, 2-bis(2,5-bis(2-benzimidazolylimino)-3A,6A-diphenyl-1,2,3,3a, 4,5,6,6a-octahydroimidazo(4,5-d)imidazole-N,N')-zinc(II)
08/28/2001CA2017252C Retroviral protease inhibiting compounds
08/25/2001CA2338258A1 Keratin fibre staining compositions containing cationic indolizine derivatives and staining process
08/23/2001WO2001060826A2 SUCCINOYLAMINO CARBOCYCLES AND HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
08/23/2001WO2001060825A1 Pyrrolopyrimidinone derivatives, process of preparation and use
08/23/2001WO2001060821A1 Novel biarylcarboxamides
08/23/2001WO2001060374A1 Use of paullone derivatives for making medicines
08/23/2001WO2001060371A1 Use of a compound for preparing a drug
08/23/2001WO2001060350A2 Method for identifying and using a2b adenosine receptor antagonists to mediate mammalian cell proliferation
08/23/2001WO2000027379A3 Pharmaceutical compositions comprising porphyrins and some novel porphyrin derivatives
08/23/2001US20010016568 Zinc chelate dimeric cell surface receptor antagonist
08/23/2001US20010016269 Guest chromophore embedded in matrix of host chromophore, or host chromophore and an effective amount of a guest chromophore both embedded in polymer matrix; electroluminescence
08/23/2001CA2400206A1 Method for identifying and using a2b adenosine receptor antagonists to mediate mammalian cell proliferation
08/23/2001CA2397560A1 Use of paullone derivatives for making medicines
08/23/2001CA2397233A1 Biarylcarboxamides
08/23/2001CA2395862A1 Succinoylamino carbocycles and heterocycles as inhibitors of a.beta. protein production
08/22/2001EP1125938A1 Protein kinase inhibitors for treatment of neurological disorders
08/22/2001EP1125937A2 Spiro [Pyrrolidine-2,3'-oxindole] compounds and methods of use
08/22/2001EP1124829A1 Tricyclic phthalazine derivatives as phosphodiesterase 4 inhibitors
08/22/2001EP1124528A1 Multivalent macrolide antibiotics
08/22/2001EP0785926B1 Carboxylic acid derivatives, their preparation and their use as medicaments
08/22/2001EP0777653B1 Dihygropyridine derivatives as bradykinin antagonists
08/22/2001CN1309561A Therapeutic agent for erection failure
08/21/2001US6278013 Optionally substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids and their derivatives
08/21/2001US6278000 Growth-hormone secretagogues
08/21/2001US6277992 Useful as an intermediate for preparing camptothecin derivatives having antitumor activities
08/21/2001US6277989 Quinazoline derivatives as medicaments
08/21/2001US6277986 Photoactivatable nitrogen-containing bases based on α-amino ketones
08/21/2001US6277985 As antibiotics; water solubility; in prodrugs
08/21/2001US6277858 For protection of plants against infestation by phytopathogenic microorganisms, i.e., fungi
08/21/2001US6277857 Fungicidal 7-oxy-and 7-thio-substituted-triazolopyrimidines
08/21/2001US6277855 Method of treating dry eye disease with nicotinic acetylcholine receptor agonists
08/21/2001US6277854 For treatment of tumor cells expressing an activated ras oncogene
08/21/2001US6277851 Bicyclic amino-pyrazinone compounds
08/21/2001US6277847 Herbicidal isoindolinonyl-and 3,4-dihydroisoquinolonyl-substituted heterocycles
08/21/2001US6277844 Administering a benzodiazepine derivative for treatment of breast, prostate and glial cell cancer
08/21/2001CA2026143C Triazole compounds, their production and use
08/21/2001CA2018751C Stable freeze dried polyhematoporphyrin ether/ester composition
08/21/2001CA2012955C Antitumor substance be-13793c
08/16/2001WO2001058906A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
08/16/2001WO2001058902A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
08/16/2001WO2001058901A1 Pyrrolopyridazine compound
08/16/2001WO2001058891A2 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage
08/16/2001WO2001058876A1 Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient
08/16/2001WO2001058871A1 Piperidyl carboxylic acids as integrin antagonists
08/16/2001WO2001058241A2 Adenosine a2a receptor antagonists for treating and preventing hepatic fibrosis, cirrhosis and fatty liver
08/16/2001WO2001010842A3 Melanocortin-4 receptor binding compounds and methods of use thereof
08/16/2001US20010014738 Process for the preparation of imidazodiazepine intermediates
08/16/2001US20010014454 Novel metal complexes
08/16/2001EP1123936A1 Fused pyridazine derivatives, process for the preparation of the same and uses thereof
08/16/2001EP1123296A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION
08/16/2001EP1123295A1 Bicyclic nitrogen heterocycles
08/16/2001EP1123293A1 Core-extended perylene bisimides
08/16/2001EP1123277A1 Epibatidine analogues as acetylcholine receptor antagonists
08/16/2001EP1066292A4 Metallocorrinoids as biologically compatible carriers of pharmacological agents
08/16/2001EP0828715B1 N-oxides as antibacterial agents
08/16/2001DE10006453A1 New piperidylcarboxylic acid derivatives, are integrin antagonists useful for treating inflammatory, autoimmune or immunological diseases, e.g. atherosclerosis, asthma, diabetes, rheumatoid arthritis or transplant rejection
08/16/2001CA2399380A1 Pyrrolopyridazine compound
08/16/2001CA2398822A1 Piperazine and piperidine derivatives
08/15/2001CN1308617A Antiviral macrocyclic compounds
08/15/2001CN1308536A Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists